Faruqi & faruqi reminds regeneron pharmaceuticals investors of the pending class action lawsuit with a lead plaintiff deadline of march 10, 2025 - regn

Faruqi & faruqi, llp securities litigation partner james (josh) wilson encourages investors who suffered losses exceeding $100,000 in regeneron to contact him directly to discuss their options new york city, ny / access newswire / january 31, 2025 / if you purchased or acquired securities in regeneron between november 2, 2023 and october 30, 2024 and would like to discuss your legal rights, call faruqi & faruqi partner josh wilson directly at 877-247-4292 or 212-983-9330 (ext. 1310). [you may also click here for additional information] faruqi & faruqi, llp, a leading national securities law firm, is investigating potential claims against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq:regn) and reminds investors of the march 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the company.
REGN Ratings Summary
REGN Quant Ranking